Women's Health Research
The FDA Office of Women's Health (OWH) promotes and conducts research initiatives that facilitate FDA regulatory decision-making and advance the understanding of sex differences and health conditions unique to women.
Women's Health Research Highlights
- Research Impact and Outcomes Framework (PDF - 5.7MB)
A guide to developing an organizational impact and outcomes measurement tool for program assessment and reporting. - Women's Health Research Roadmap
A roadmap outlining a strategic direction for future OWH-funded research to help maximize the impact of OWH initiatives and promote optimal health for women. - OWH-Funded Research Projects - by Funding Year
List of Research Program Awards by Funding Year - FDA Office of Women's Health - OWH-Funded Research Projects - by Topic Area
FDA OWH awards research grants studies to support FDA regulatory decision-making and advance the science of women’s health. - Research on Heart Disease in Women
FDA’s Office of Women’s Health supports research to provide valuable insight into sex differences in the diagnosis and treatment of cardiovascular disease. - List of Publications from OWH-Funded Research
List of Publications from FDA Office of Women's Health Supported Studies - Pregnancy Exposure Registries
Pregnancy exposure registries - White Paper on Successful Strategies for Engaging Women and Minorities in Clinical Trials (PDF - 1.2MB)
White Paper on the Dialogues on Diversifying Clinical Trials Conference - FDASIA Section 907 Report: Collection, Analysis, and Availability of Demographic Subgroup Data for FDA-Approved Medical Products (PDF - 1.6MB)
- FDASIA Section 907 Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data
Training Resources
- The Science of Sex and Gender in Human Health
Free CE Courses developed by the FDA Office of Women's Health and NIH Office of Research on Women's Health
.png)
No hay comentarios:
Publicar un comentario